← Leaderboards
Ana Paula Galvao Da Silva
Siamab Therapeutics, Inc.
$222,319
Attributed
$222,319
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$222,319 · 1
By mechanism
N43$222,319 · 1
Top collaborators
No co-investigators on record.
Most similar at Siamab Therapeutics, Inc.
Same institution · by research overlap
- Elaine Anselmo Muchmore$202,116
- Nancy Hurtado-Ziola$952,415
- Jillian Marie Prendergast$219,846
- David Eavarone$1,499,399
Others in their field
Top investigators on “Cancer Stem Cell”
- David Heimbrook · Leidos Biomedical Research, Inc.$162,492,362
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,653,178
- Mary M Horowitz · Medical College Of Wisconsin$154,320,720
- Todd A Alonzo · University Of Colorado Denver/Hsc Denver$62,800,467
- Timothy J Eberlein · Washington University$49,931,668
- Elaine Fuchs · University Of Chicago$38,905,243
Research focus
Cancer Stem CellPolysaccharides